For example, mutations in TP53, Kirsten Rat Sarcoma (KRAS), and AT‐Rich Interaction Domain 1A (ARID1A) genes have been associated with cholangiocarcinoma [111]. This evidence concerns the gene TP53 and cholangiocarcinoma.